Protagenic Therapeutics, Inc.\new Related Party Transaction, Expenses from Transactions with Related Party
Protagenic Therapeutics, Inc.\new (PTIX) reported Related Party Transaction, Expenses from Transactions with Related Party of $300.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2022-04-07
- Protagenic Therapeutics, Inc.\new related party transaction, expenses from transactions with related party for fiscal 2021 was $300.00K.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|
| 2021-12-31 | $300.00K 10-K · filed 2022-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |